E-DRUG: SG's High-level Panel on Access to Medicines - deadline extended to 28 Feb
------------------------------------------------------------------------------------------------------
E-druggers, please note that the UN High-level panel on Access to Medicines
has extended the deadline for submissions from 18 to 28 February 2016.
See http://www.unsgaccessmeds.org/call-for-contributions
What will the High-Level Panel be considering?
The High-Level Panel is inviting contributions that address the policy
incoherence in relation to the rights of inventors, international human
rights law, trade rules, and public health objectives including increased
access to medicines, vaccines, diagnostics and medical devices ('health
technologies'). In accordance with Sustainable Development Goal 3, and the
integrated nature of the 2030 Agenda for Sustainable Development,
contributions are not limited to any specific set of countries or any
diseases.
Submitted contributions should be:
. evidence-informed and include references to the principles, literature and
models upon which the contribution is based,
. reflect, align and demonstrate how it will support the attainment of the
2030 Agenda for Sustainable Development and in particular, Sustainable
Development Goal 3, that aims to improve the health and wellbeing for all,
and
. where applicable, indicate the political, financial or other requirements
to the implement of the proposed ideas.
While critical to the attainment of health outcomes, broader issues relating
to health systems strengthening and supply chain management fall outside of
the scope of the enquiry by the High- Level Panel.
What sort of contributions is the High-Level Panel looking for?
The Panel looks to receive contributions that will enhance and strengthen
the promotion of innovation and access to medicines, vaccines and
diagnostics. The Panel welcomes contributions of varying ambition and scope
- it welcomes contributions that propose the recalibration of existing
mechanisms that address the rights of inventors, international human rights
law, trade rules, and public health objectives. It also encourages
contributions that may be narrower in scope and that propose
If our/your submission gets shortlisted, there is a chance to present it at
two public hearings will be held to review proposals (9-10 March London /
17-19 March Johannesburg)
E-DRUG@healthnet.org
"Wilbert Bannenberg" <wjb@wxs.nl>